Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
3(23%)
Results Posted
0%(0 trials)
Terminated
2(15%)

Phase Distribution

Ph not_applicable
2
15%
Ph phase_2
1
8%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Recruiting3
Not yet recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)

Trials by Status

completed646%
not_yet_recruiting215%
recruiting323%
terminated215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
13